These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30832611)

  • 1. Neuropsychiatric events in an adult patient with influenza a (H3N2) treated with oseltamivir (Tamiflu): a case report.
    Chen R; Fang Z; Huang Y
    BMC Infect Dis; 2019 Mar; 19(1):224. PubMed ID: 30832611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different drug-resistant influenza A(H3N2) variants in two immunocompromised patients treated with oseltamivir during the 2011-2012 influenza season in Italy.
    Piralla A; Gozalo-Margüello M; Fiorina L; Rovida F; Muzzi A; Colombo AA; Alessandrino PE; Baldanti F
    J Clin Virol; 2013 Sep; 58(1):132-7. PubMed ID: 23810646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.
    Smith JR; Sacks S
    Int J Clin Pract; 2009 Apr; 63(4):596-605. PubMed ID: 19335705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.
    Toovey S; Rayner C; Prinssen E; Chu T; Donner B; Thakrar B; Dutkowski R; Hoffmann G; Breidenbach A; Lindemann L; Carey E; Boak L; Gieschke R; Sacks S; Solsky J; Small I; Reddy D
    Drug Saf; 2008; 31(12):1097-114. PubMed ID: 19026027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of ozeltamivir (Tamiflu) in adult influenza on the epidemic rise of morbidity in Russia in the 2006-2007 season].
    Kolobukhina LV; Merkulova LN; Burtseva EI; Isaeva EI; Shchelkanov MIu; Beliakova NV; Grebennikova TV; Polikushina OE; Rotanov M; Malyshev NA; L'vov DK
    Vopr Virusol; 2008; 53(4):23-6. PubMed ID: 18756812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of a child who developed abnormal neuropsychiatric symptoms after administration of oseltamivir: a case report.
    Morimoto K; Nagaoka K; Nagai A; Kashii H; Hosokawa M; Takahashi Y; Ogihara T; Kubota M
    BMC Neurol; 2015 Aug; 15():130. PubMed ID: 26242979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective surveillance of antiviral resistance in hospitalized infants less than 12 months of age with A(H3N2) influenza infection and treated with oseltamivir.
    Rath B; Chen X; Spies V; Muehlhans S; Obermeier P; Tief F; Seeber L; Karsch K; Milde J; Skopnik H; Schweiger B; Duwe SC
    Antivir Ther; 2017; 22(6):515-522. PubMed ID: 28205506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged shedding of amantadine- and oseltamivir-resistant influenza A(H3N2) virus with dual mutations in an immunocompromised infant.
    Ruiz-Carrascoso G; Casas I; Pozo F; González-Vincent M; Pérez-Breña P
    Antivir Ther; 2010; 15(7):1059-63. PubMed ID: 21041923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
    Nakamura K; Schwartz BS; Lindegårdh N; Keh C; Guglielmo BJ
    Clin Infect Dis; 2010 Apr; 50(7):e47-9. PubMed ID: 20192728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia.
    L'Huillier AG; Ing Lorenzini K; Crisinel PA; Rebsamen MC; Fluss J; Korff CM; Barbe RP; Siegrist CA; Dayer P; Posfay-Barbe KM; Desmeules JA;
    Pharmacogenomics; 2011 Oct; 12(10):1493-501. PubMed ID: 21902503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oseltamivir- related psychiatric manifestations.
    Guisado-Macías JA; Rodríguez FF; Méndez-Sánchez F; Bolívar-Perálvarez M
    Actas Esp Psiquiatr; 2012; 40(1):46-8. PubMed ID: 22344496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of oseltamivir in patients with influenza: analysis of healthcare claims data from six influenza seasons.
    Blumentals WA; Song X
    MedGenMed; 2007 Oct; 9(4):23. PubMed ID: 18311373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The smaller number of influenza patients with neuropsychiatric events had taken oseltamivir beforehand].
    Tomono N; Shiro H
    Kansenshogaku Zasshi; 2008 Nov; 82(6):613-8. PubMed ID: 19086415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The virologist and the flu.
    Wicker S; Rabenau HF
    J Clin Virol; 2015 Aug; 69():200-2. PubMed ID: 26209407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza-associated mortality in hospital care: a retrospective cohort study of risk factors and impact of oseltamivir in an English teaching hospital, 2016 to 2017.
    Reacher M; Warne B; Reeve L; Verlander NQ; Jones NK; Ranellou K; Christou S; Wright C; Choudhry S; Zambon M; Sander C; Zhang H; Jalal H
    Euro Surveill; 2019 Oct; 24(44):. PubMed ID: 31690364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of Japanese infants younger than 3 months who were treated with oseltamivir for influenza: safety of oseltamivir treatment.
    Morioka I; Nonoyama S; Tanaka-Taya K; Ihara T; Sugaya N; Ueta I; Kumagai T; Okada K; Hosoya M; Okabe N; Morishima T;
    Scand J Infect Dis; 2012 Aug; 44(8):605-9. PubMed ID: 22497443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
    J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
    Sugaya N; Tamura D; Yamazaki M; Ichikawa M; Kawakami C; Kawaoka Y; Mitamura K
    Clin Infect Dis; 2008 Aug; 47(3):339-45. PubMed ID: 18582202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.
    Kawai N; Ikematsu H; Iwaki N; Maeda T; Kawashima T; Hirotsu N; Kashiwagi S
    Clin Infect Dis; 2009 Apr; 48(7):996-7. PubMed ID: 19260819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.